BEONE MEDICINES LTD. Income (Loss) from Equity Method Investments
BEONE MEDICINES LTD. (ONC) reported Income (Loss) from Equity Method Investments of -$576.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2025-11-06
- BEONE MEDICINES LTD. income (loss) from equity method investments for the quarter ending 2025-09-30 was -$576.00K.
- BEONE MEDICINES LTD. income (loss) from equity method investments for the quarter ending 2025-06-30 was -$1.90M.
- BEONE MEDICINES LTD. income (loss) from equity method investments for the quarter ending 2025-03-31 was -$13.38M.
- BEONE MEDICINES LTD. income (loss) from equity method investments for the quarter ending 2024-09-30 was -$2.94M.
- BEONE MEDICINES LTD. income (loss) from equity method investments for fiscal 2023 was -$16.22M.
- BEONE MEDICINES LTD. income (loss) from equity method investments for fiscal 2022 was -$22.00M, a 388.21% decline from fiscal 2021.
- BEONE MEDICINES LTD. income (loss) from equity method investments for fiscal 2021 was $7.63M, a 35.46% decline from fiscal 2020.
- BEONE MEDICINES LTD. income (loss) from equity method investments for fiscal 2020 was $11.83M.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 9 month as first filed | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | -$576.00K 10-Q · filed 2025-11-06 | -$2.48M derived: sum of 2 quarters · filed 2025-11-06 | -$15.85M 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | -$1.90M 10-Q · filed 2025-08-06 | -$15.27M 10-Q · filed 2025-08-06 | |||
| 2025-03-31 | -$13.38M 10-Q · filed 2025-05-07 | ||||
| 2024-09-30 | -$2.94M 10-Q · filed 2025-11-06 | -$6.95M derived: sum of 2 quarters · filed 2025-11-06 | -$7.81M 10-Q · filed 2025-11-06 | -$18.73M derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | -$4.02M 10-Q · filed 2025-08-06 | -$4.87M 10-Q · filed 2025-08-06 | -$15.79M derived: sum of 3 quarters · filed 2025-08-06 | -$18.47M derived: sum of 4 quarters · filed 2025-08-06 | |
| 2024-03-31 | -$856.00K 10-Q · filed 2025-05-07 | -$11.78M derived: sum of 2 quarters · filed 2025-05-07 | -$14.45M derived: sum of 3 quarters · filed 2025-05-07 | -$16.46M derived: sum of 4 quarters · filed 2025-05-07 | |
| 2023-12-31 | -$10.92M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$13.60M derived: sum of 2 quarters · filed 2024-11-12 | -$15.61M derived: sum of 3 quarters · filed 2024-11-12 | -$16.22M 10-K · filed 2024-02-26 | |
| 2023-09-30 | -$2.67M 10-Q · filed 2024-11-12 | -$4.68M derived: sum of 2 quarters · filed 2024-11-12 | -$5.30M 10-Q · filed 2024-11-12 | -$12.27M 10-Q · filed 2023-11-09 | -$10.44M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$2.18M 10-Q · filed 2023-08-02 | -$7.76M derived: sum of 3 quarters · filed 2024-02-26 | -$645.00K derived: sum of 4 quarters · filed 2024-02-26 | |
| 2023-03-31 | -$169.00K 10-Q · filed 2023-05-04 | -$5.75M derived: sum of 2 quarters · filed 2024-02-26 | $1.36M derived: sum of 3 quarters · filed 2024-02-26 | -$5.19M derived: sum of 4 quarters · filed 2024-02-26 | |
| 2022-12-31 | -$5.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $1.53M derived: sum of 2 quarters · filed 2024-02-26 | -$5.02M derived: sum of 3 quarters · filed 2024-02-26 | -$22.00M 10-K · filed 2024-02-26 | |
| 2022-09-30 | $7.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $561.00K derived: sum of 2 quarters · filed 2023-11-09 | -$16.41M 10-Q · filed 2023-11-09 | -$25.95M derived: sum of 4 quarters · filed 2024-02-26 | |
| 2022-06-30 | -$6.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$23.53M 10-Q · filed 2023-08-02 | -$33.06M derived: sum of 3 quarters · filed 2024-02-26 | -$9.86M derived: sum of 4 quarters · filed 2024-02-26 | |
| 2022-03-31 | -$16.97M 10-Q · filed 2023-05-04 | -$26.51M derived: sum of 2 quarters · filed 2024-02-26 | -$3.31M derived: sum of 3 quarters · filed 2024-02-26 | -$6.01M derived: sum of 4 quarters · filed 2024-02-26 | |
| 2021-12-31 | -$9.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $13.66M derived: sum of 2 quarters · filed 2024-02-26 | $10.96M derived: sum of 3 quarters · filed 2024-02-26 | $7.63M 10-K · filed 2024-02-26 | |
| 2021-09-30 | $23.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $20.49M derived: sum of 2 quarters · filed 2022-11-09 | $17.17M 10-Q · filed 2022-11-09 | $19.02M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-06-30 | -$2.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$6.03M 10-Q · filed 2022-08-08 | -$4.18M derived: sum of 3 quarters · filed 2023-02-27 | -$5.47M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-03-31 | -$3.33M 10-Q · filed 2022-05-09 | -$1.48M derived: sum of 2 quarters · filed 2023-02-27 | -$2.77M derived: sum of 3 quarters · filed 2023-02-27 | $1.53M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2020-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $562.00K derived: sum of 2 quarters · filed 2023-02-27 | $4.86M derived: sum of 3 quarters · filed 2023-02-27 | $11.83M 10-K · filed 2023-02-27 | |
| 2020-09-30 | -$1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $3.01M derived: sum of 2 quarters · filed 2021-11-04 | $9.97M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $11.26M 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | $6.96M 10-Q · filed 2021-05-06 | ||||
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 | ||||
| 2018-12-31 | $0.00 10-K · filed 2021-02-25 |